Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Care & Hematology Specialists of Chicagoland
Arlington Heights, Illinois, United States
- Hematology/oncology Associates
Chicago, Illinois, United States
- Northwestern University, Northwestern Medical Faculty Foundation
Chicago, Illinois, United States
- Joliet Oncology-Hematology Associates, Ltd.
Joliet, Illinois, United States
- Hope Cancer Center
Terre Haute, Indiana, United States
- Cancer Center of Kansas
Wichita, Kansas, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Virtua Memorial (regional Cancer Care Associates of Mount Holly)
Mount Holly, New Jersey, United States
- Mercy Clinic Oncology and Hematology
Oklahoma City, Oklahoma, United States
- the Jones Clinic
Germantown, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Jan 2010
- Primary completion
- 31 Jan 2015
- Completion
- 31 Jan 2015
- Last update posted
- 7 May 2019
- Registered enrollment
- 28
- Registry id
- NCT00940316
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.